---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-007143"
form_type: "8-K"
ticker: "TMCI"
cik: "0001630627"
company_name: "TREACE MEDICAL CONCEPTS, INC."
filed_at: "2022-05-04T23:59:59+00:00"
generated_at: "2026-06-26T00:45:26.837899+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Treace Medical closes $54M draw on $150M MidCap debt facility; refinances $30M CRG loan

## Summary
- $150M total facility ($120M term + $30M revolver) with MidCap; $54M drawn at closing.
- Proceeds used to refinance existing $30M CRG term loan and replace $10M SVB revolver.
- Interest: Adjusted Term SOFR (floor 1%, cap 3%) + 6% (term) or 4% (revolver); 48-month interest-only.
- Liquidity now ~$220M including undrawn revolver; no min revenue covenant if liquidity > outstanding term loan.
- CEO John Treace says financing provides capital-efficient vehicle to invest in growth.

## SEC filing metadata
- accession: 0000950170-22-007143
- form_type: 8-K
- ticker: TMCI
- cik: 0001630627
- company_name: TREACE MEDICAL CONCEPTS, INC.
- filed_at: 2022-05-04T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630627/000095017022007143/0000950170-22-007143-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630627/000095017022007143/tmci-20220429.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-007143
- JSON: https://secwatch.observer/filing/0000950170-22-007143.json
- Plain text: https://secwatch.observer/filing/0000950170-22-007143.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.